These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 7867594)

  • 21. 1,25-dihydroxycholecalciferol: endocrinology meets the immune system.
    van Etten E; Decallonne B; Mathieu C
    Proc Nutr Soc; 2002 Aug; 61(3):375-80. PubMed ID: 12230797
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The in vivo effect of a new, in vitro, extremely potent vitamin D3 analog KH1060 on the suppression of renal allograft rejection in the rat.
    Lewin E; Olgaard K
    Calcif Tissue Int; 1994 Feb; 54(2):150-4. PubMed ID: 8012870
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A vitamin D analogue (EB1089) inhibits parathyroid hormone-related peptide production and prevents the development of malignancy-associated hypercalcemia in vivo.
    Haq M; Kremer R; Goltzman D; Rabbani SA
    J Clin Invest; 1993 Jun; 91(6):2416-22. PubMed ID: 8514854
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Selective biological response by target organs (intestine, kidney, and bone) to 1,25-dihydroxyvitamin D3 and two analogues.
    Norman AW; Sergeev IN; Bishop JE; Okamura WH
    Cancer Res; 1993 Sep; 53(17):3935-42. PubMed ID: 8395333
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Vitamin D and 1,25-dihydroxyvitamin D3 as modulators in the immune system.
    Mathieu C; van Etten E; Decallonne B; Guilietti A; Gysemans C; Bouillon R; Overbergh L
    J Steroid Biochem Mol Biol; 2004 May; 89-90(1-5):449-52. PubMed ID: 15225818
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Vitamin D analogs with low affinity for the vitamin D binding protein: enhanced in vitro and decreased in vivo activity.
    Bouillon R; Allewaert K; Xiang DZ; Tan BK; van Baelen H
    J Bone Miner Res; 1991 Oct; 6(10):1051-7. PubMed ID: 1796753
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Changes in mineral metabolism in stage 3, 4, and 5 chronic kidney disease (not on dialysis)].
    Lorenzo Sellares V; Torregrosa V
    Nefrologia; 2008; 28 Suppl 3():67-78. PubMed ID: 19018742
    [TBL] [Abstract][Full Text] [Related]  

  • 28. 19-nor-26,27-bishomo-vitamin D3 analogs: a unique class of potent inhibitors of proliferation of prostate, breast, and hematopoietic cancer cells.
    Kubota T; Koshizuka K; Koike M; Uskokovic M; Miyoshi I; Koeffler HP
    Cancer Res; 1998 Aug; 58(15):3370-5. PubMed ID: 9699668
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Comparison of 22-oxacalcitriol and 1,25(OH)2D3 on bone metabolism in young X-linked hypophosphatemic male mice.
    Halstead LR; Weinstein RS; Cheng SL; Rifas L; Avioli LV
    Am J Physiol; 1996 Jan; 270(1 Pt 1):E141-7. PubMed ID: 8772486
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Conformational change and enhanced stabilization of the vitamin D receptor by the 1,25-dihydroxyvitamin D3 analog KH1060.
    van den Bemd GC; Pols HA; Birkenhäger JC; van Leeuwen JP
    Proc Natl Acad Sci U S A; 1996 Oct; 93(20):10685-90. PubMed ID: 8855240
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Oral administration of 1,25-dihydroxyvitamin D3 completely protects NOD mice from insulin-dependent diabetes mellitus.
    Zella JB; McCary LC; DeLuca HF
    Arch Biochem Biophys; 2003 Sep; 417(1):77-80. PubMed ID: 12921782
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Biological activity assessment of 1 alpha,25-dihydroxyvitamin D3-26,23-lactone and its intermediate metabolites in vivo and in vitro.
    Ishizuka S; Sumitani K; Hiura K; Kawata T; Okawa M; Hakeda Y; Kumegawa M
    Endocrinology; 1990 Aug; 127(2):695-701. PubMed ID: 2373050
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Analogs of 1alpha,25-dihydroxyvitamin D3 as pluripotent immunomodulators.
    Van Etten E; Decallonne B; Verlinden L; Verstuyf A; Bouillon R; Mathieu C
    J Cell Biochem; 2003 Feb; 88(2):223-6. PubMed ID: 12520518
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Immune modulation by vitamin D analogs in the prevention of autoimmune diseases].
    Bouillon R; Verstuyf A; Branisteanu D; Waer M; Mathieu C
    Verh K Acad Geneeskd Belg; 1995; 57(5):371-85; discussion 385-7. PubMed ID: 8571669
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Human and murine osteocalcin gene expression: conserved tissue restricted expression and divergent responses to 1,25-dihydroxyvitamin D3 in vivo.
    Sims NA; White CP; Sunn KL; Thomas GP; Drummond ML; Morrison NA; Eisman JA; Gardiner EM
    Mol Endocrinol; 1997 Oct; 11(11):1695-708. PubMed ID: 9328351
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Synergistic inhibitory effect of cyclosporin A and vitamin D derivatives on T-lymphocyte proliferation in active ulcerative colitis.
    Stio M; Treves C; Celli A; Tarantino O; d'Albasio G; Bonanomi AG
    Am J Gastroenterol; 2002 Mar; 97(3):679-89. PubMed ID: 11922564
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Comparative study of the effect of 1,25 dihydroxyvitamin D3 and 24,25-dihydroxyvitamin D3 on calcium homeostasis and bone tissue state in rats during hypokinesia].
    Sergeev IN; Blazheevich NV; Kaplanskiĭ AS; Shvets VN; Belakovskiĭ MS
    Vopr Med Khim; 1987; 33(1):100-7. PubMed ID: 3495067
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effects of 1,25-dihydroxyvitamin D3 and its 20-epi analogues (MC 1288, MC 1301, KH 1060), on clonal keratinocyte growth: evidence for differentiation of keratinocyte stem cells and analysis of the modulatory effects of cytokines.
    Gniadecki R
    Br J Pharmacol; 1997 Mar; 120(6):1119-27. PubMed ID: 9134225
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prevention of murine experimental allergic encephalomyelitis: cooperative effects of cyclosporine and 1 alpha, 25-(OH)2D3.
    Branisteanu DD; Waer M; Sobis H; Marcelis S; Vandeputte M; Bouillon R
    J Neuroimmunol; 1995 Sep; 61(2):151-60. PubMed ID: 7593550
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Vitamin D analogs, 20-Epi-22-oxa-24a,26a,27a,-trihomo-1alpha,25(OH)2-vitamin D3, 1,24(OH)2-22-ene-24-cyclopropyl-vitamin D3 and 1alpha,25(OH)2-lumisterol3 prime NB4 leukemia cells for monocytic differentiation via nongenomic signaling pathways, involving calcium and calpain.
    Berry DM; Meckling-Gill KA
    Endocrinology; 1999 Oct; 140(10):4779-88. PubMed ID: 10499538
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.